<![CDATA[Genmab Announces U.S. FDA Approval]]>Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) Split Dosing Regimen
February 12, 2019 at 7:07 AM CET

Media Release:

Copenhagen, Denmark, February 12, 2019

DARZALEX split dosing regimen approved by U.S. FDA
Provides healthcare professionals with option to split first DARZALEX infusion over two consecutive days
Approval supported by data from EQUULEUS (MMY1001) clinical tria

Læs mere:

https://ir.genmab.com/news-releases/news-release-details/genmab-announces-us-fda-approval-darzalexr-daratumumab-split

]]>https://dev.proinvestor.com/forum/topic/440066/genmab-announces-us-fda-approvalRSS for NodeWed, 15 Jul 2026 19:11:35 GMTTue, 12 Feb 2019 05:21:58 GMT60